Gareth Winckle

Title: Gareth Winckle and His Patent on a Hydrogel for Radiation-Related Skin Damage.

Introduction

Gareth Winckle is an inventor associated with Tarian Pharma and based in Juan-les-Pins, France. His patent work includes a topical hydrogel composition intended to help prevent or treat skin damage caused by radiation.

Latest Patents

Winckle is associated with 1 patent: “Hydrogel Composition and Uses Thereof in the Prevention and/or Treatment of Skin Damage Caused by Radiation.” The patent describes a water-based topical composition containing the vasoconstrictor brimonidine or its salts, alongside polyethylene glycol combined with propylene glycol and/or dimethyl sulfoxide. It also specifies hydrophilic film-forming agents, including polyvinylpyrrolidone-based materials, and glycerine in hydrogel form.

The disclosed methods involve administering the composition to a patient to prevent or treat radiation-related dermatitis, including skin effects associated with radiotherapy.

Career Highlights

Winckle’s listed patent reflects work on a topical formulation designed for use in addressing skin damage caused by radiation. He is associated with Tarian Pharma.

Collaborations

The supplied information names Philippe Andres and Janusz Czernielewski as Winckle’s coworkers. Their connection to the patent or to specific research activities is not detailed in the available information.

Conclusion

Gareth Winckle’s patent activity centers on a hydrogel formulation intended to prevent or treat radiation-related skin damage, including dermatitis associated with radiotherapy.